Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sanyou, Sinorda Partner to Advance Bispecific Antibody Drug Development | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Sanyou, Sinorda Partner to Advance Bispecific Antibody Drug Development

Will leverage Sanyou's core technology R&D platform and Sinorda's experience in preclinical and clinical oncology immunotherapy.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanyou Biopharmaceuticals and Sinorda Biomedicine entered into a strategic cooperation agreement to advance innovative bispecific antibody drug development.

The collaboration will leverage Sanyou’s core technology platform for integrated R&D and preclinical development and “super-trillion innovative biologics discovery platform”, and Sinorda’s experience in preclinical and clinical oncology immunotherapy.

Pingsheng Hu, CEO of Sinorda, said, “Sinorda focuses on the research and development of innovative drug and industrialization of oncology immunotherapy. Our partnership with Sanyou merges our strengths, accelerating the drug development process and transforming innovative achievements into reality faster. This collaboration improves treatment choices for patients. With this shared vision, we can work together to advance innovative drug products and contribute to human health.”

Guojun Lang, CEO of Sanyou, said, “We’re truly honored to establish a strategic cooperation with Sinorda. Their strong scientific and medical expertise, robust clinical capabilities, and extensive experience in industrial collaboration perfectly align with Sanyou. Both Sanyou and Sinorda share the common goal of using biopharmaceutical technology to enhance human health. Our combined strengths and robust collaboration will open new opportunities and forge a pioneering model of cooperation between innovative drug research and development services and pharmaceutical enterprises.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics